Literature DB >> 26195458

Hyperreactive Malarial Splenomegaly Syndrome--Can the Diagnostic Criteria Be Improved?

Alastair McGregor1, Tom Doherty2, Patricia Lowe2, Peter Chiodini2, William Newsholme2.   

Abstract

Hyperreactive Malarial Splenomegaly Syndrome (HMSS) was described and defined before sensitive tests for malaria were available. We present a series of seven individuals who were referred to our clinics with possible HMSS. Chronic malaria was demonstrated in those successfully treated but not in those who failed to respond to therapy. This observation suggests that the newer molecular malaria assays have a role to play in the identification of individuals who are likely to respond to treatment for HMSS in non-endemic regions. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2015        PMID: 26195458      PMCID: PMC4559700          DOI: 10.4269/ajtmh.14-0234

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  The hyperreactive malarial splenomegaly syndrome in a European: has the treatment a modulatory effect on the immune system?

Authors:  D C Betticher; A Nicole; P Pugin; C Regamey
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

2.  Tropical splenomegaly syndrome: long-term proguanil therapy correlated with spleen size, serum IgM, and lymphocyte transformation.

Authors:  A S Sagoe
Journal:  Br Med J       Date:  1970-08-15

3.  Validation of PCR for detection and characterization of parasitaemia in massive splenomegaly attributed clinically to malaria infection.

Authors:  Salwa M E A-Elgayoum; El-Amin El-Rayah; Hayder A Giha
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-12       Impact factor: 2.803

4.  [Hyperreactive malarial splenomegaly: three clinical cases and literature review].

Authors:  B Camara; J-B Kantambadouno; G Martin-Blondel; A Berry; M Alvarez; F Benoit-Vical; J Delmont; O Bouchaud; B Marchou
Journal:  Med Mal Infect       Date:  2008-10-25       Impact factor: 2.152

5.  Tropical splenomegaly syndrome in Zambia: further observations and effects of cycloguanil and proguanil.

Authors:  M N Lowenthal; E C O'Riordan; M S Hutt
Journal:  Br Med J       Date:  1971-02-20

6.  Tropical splenomegaly syndrome in a Rwandan kindred in Uganda.

Authors:  J L Ziegler; P C Stuiver
Journal:  Br Med J       Date:  1972-07-08

7.  Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections.

Authors:  G Snounou; S Viriyakosol; W Jarra; S Thaithong; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

8.  Reduction of suppressor T lymphocytes in the tropical splenomegaly syndrome.

Authors:  S L Hoffman; W F Piessens; S Ratiwayanto; P R Hussein; L Kurniawan; P W Piessens; J R Campbell; H A Marwoto
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

9.  Antibody-mediated killing of suppressor T lymphocytes as a possible cause of macroglobulinemia in the tropical splenomegaly syndrome.

Authors:  W F Piessens; S L Hoffman; A A Wadee; P W Piessens; S Ratiwayanto; L Kurniawan; J R Campbell; H A Marwoto; L L Laughlin
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

Review 10.  Tropical splenomegaly. Part 1: Tropical Africa.

Authors:  Y M Fakunle
Journal:  Clin Haematol       Date:  1981-10
View more
  5 in total

1.  Case Report: Hyperreactive Malarial Splenomegaly Syndrome Diagnosed with Loop-Mediated Isothermal Amplification and Treated with Artemisinin-Based Combination Therapy.

Authors:  Francesco G Genderini; Cecile Haeseleer; Brigitte Cantinieaux; Charlotte Martin
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

2.  Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model.

Authors:  Norinne Lacerda-Queiroz; Nicolas Riteau; Richard T Eastman; Kevin W Bock; Marlene S Orandle; Ian N Moore; Alan Sher; Carole A Long; Dragana Jankovic; Xin-Zhuan Su
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

Review 3.  Histoplasmosis in African children: clinical features, diagnosis and treatment.

Authors:  Bassey Ewa Ekeng; Kevin Edem; Patricia Akintan; Rita O Oladele
Journal:  Ther Adv Infect Dis       Date:  2022-01-21

4.  Macrophage migration inhibitory factor contributes to immunopathogenesis during Plasmodium yoelii 17XL infection.

Authors:  Víctor H Salazar-Castañón; Imelda Juárez-Avelar; Martha Legorreta-Herrera; Miriam Rodriguez-Sosa
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

5.  Chronic malaria and hyper-reactive malarial splenomegaly: a retrospective study on the largest series observed in a non-endemic country.

Authors:  Zeno Bisoffi; Stefania Leoni; Andrea Angheben; Anna Beltrame; Franklyn Esoka Eseme; Federico Gobbi; Claudia Lodesani; Stefania Marocco; Dora Buonfrate
Journal:  Malar J       Date:  2016-04-21       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.